Volume 63, Issue 3, Pages 1051-1057 (March 2003) High-dose intravenous melphalan with autologous stem cell transplantation in AL amyloidosis-associated end-stage renal disease Liam F. Casserly, Amit Fadia, Vaishali Sanchorawala, David C. Seldin, Daniel G. Wright, Martha Skinner, Laura M. Dember Kidney International Volume 63, Issue 3, Pages 1051-1057 (March 2003) DOI: 10.1046/j.1523-1755.2003.00813.x Copyright © 2003 International Society of Nephrology Terms and Conditions
Figure 1 Survival from time of treatment of end-stage renal disease (ESRD) patients compared with non-ESRD patients (P = 0.1 by log-rank test). Kidney International 2003 63, 1051-1057DOI: (10.1046/j.1523-1755.2003.00813.x) Copyright © 2003 International Society of Nephrology Terms and Conditions